Not applicableUnknownNCT04528940What this trial is testingTumor Grade Determines PD-1/PDL-1 ExpressionWho this might be right forEndometrial CancerOvarian Cancer RWJ Barnabas Health at Jersey City Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00795808What this trial is testingPCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With ClomipheneWho this might be right forPolycystic Ovary Syndrome University of Auckland, New Zealand 171
Testing effectiveness (Phase 2)Study completedNCT06087289What this trial is testingEvaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697What this trial is testingAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaWho this might be right forMesotheliomaNeoplasmsStomach Neoplasms+5 more National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT03933813What this trial is testingEvaluation and Treatment of Iron Deficiency in Ovarian Cancer PatientsWho this might be right forEpithelial Ovarian CancerAnemiaIron Deficiency Anemia University of Wisconsin, Madison 9
Early research (Phase 1)Study completedNCT02146313What this trial is testingA Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerWho this might be right forPancreatic NeoplasmsOvarian Neoplasms Genentech, Inc. 35
Early research (Phase 1)Ended earlyNCT00637390What this trial is testingA Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.Who this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer University of Michigan Rogel Cancer Center 3
Not applicableStudy completedNCT00340210What this trial is testingExtended Follow-up of Columbia, MO Serum Bank ParticipantsWho this might be right forBreast CancerEndometrial CancerOvarian Cancer National Cancer Institute (NCI) 6,720
Not applicableLooking for participantsNCT06392997What this trial is testingEvaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic PathologyWho this might be right forGynecologic DiseaseGynecologic CancerEndometriosis+5 more ZIWIG 2,500
Testing effectiveness (Phase 2)Study completedNCT01001910What this trial is testingPemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma Albert Einstein College of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT02335918What this trial is testingA Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsWho this might be right forSquamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more Celldex Therapeutics 175
Early research (Phase 1)Study completedNCT00848510What this trial is testingEMD 525797 in Colorectal and Ovarian Cancer Patients With Liver MetastasesWho this might be right forColorectal and Ovarian Cancer Patients With Liver Metastases Merck KGaA, Darmstadt, Germany 41
Large-scale testing (Phase 3)Study completedNCT00262990What this trial is testingPatupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Neoplasms Novartis Pharmaceuticals 829
Not applicableNo Longer AvailableNCT03063710What this trial is testingOlaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in JapanWho this might be right forPSR Ovarian Cancer With a BRCA Mutation AstraZeneca
Large-scale testing (Phase 3)Not Yet RecruitingNCT07550205What this trial is testingTiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian CancerWho this might be right forOvarian Neoplasms MalignantSleep Initiation and Maintenance DisordersMedicine, Chinese Traditional+2 more Shanghai Municipal Hospital of Traditional Chinese Medicine 360
Testing effectiveness (Phase 2)Ended earlyNCT00331422What this trial is testingCarboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Masonic Cancer Center, University of Minnesota 7
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Early research (Phase 1)Study completedNCT01975831What this trial is testingEvaluate MEDI4736 in Combination With TremelimumabWho this might be right forBreast CancerOvarian CancerColorectal Cancer+2 more Ludwig Institute for Cancer Research 104
Testing effectiveness (Phase 2)UnknownNCT03262545What this trial is testingEfficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian CancerWho this might be right forAngiogenesis Inhibitors，Ovarian Neoplasms Sichuan Cancer Hospital and Research Institute 60
Not applicableStudy completedNCT00488202What this trial is testingAdvanced Ovarian Cancer and Sexuality Phase 1Who this might be right forOvarian CancerSexual Function University of British Columbia 26